Publications
128
Citations
3,835
Est. group size
~35
Recurring co-author estimate
Active years
18
Publishing since 2009
Typically publishes in teams of ~11 · 10% small-team papers (≤3 authors) · across 23 venues
- Prospective Phase II Trial of Definitive Chemoradiation and Concurrent Nivolumab in Locally Advanced p16+ Oropharynx Cancer
Advances in Radiation Oncology · 2025
- Addressing knowledge gaps in HPV-related oropharyngeal cancer prevention: A call for action
Oral Oncology · 2025
- A United States study of self-collected urine vs clinician-collected cervical sample for HPV and cervical intraepithelial neoplasia grade two or worse detection: Cross-sectional agreement and diagnostic accuracy study
Preventive Medicine Reports · 2025
- RETRACTED: Cervicovaginal and Anal Self-Sampling for Human Papillomavirus Testing in a Transgender and Gender Diverse Population Assigned Female at Birth: Comfort, Difficulty, and Willingness to Use
LGBT Health · 2024
- Prevalence and Determinants of Cervicovaginal, Oral, and Anal Human Papillomavirus Infection in a Population of Transgender and Gender Diverse People Assigned Female at Birth
LGBT Health · 2024
- Cervical Health in Systemic Lupus Erythematosus
Women s Health Reports · 2023
- Cervicovaginal and anal self-sampling for HPV testing in a transgender and gender diverse population assigned female at birth: comfort, difficulty, and willingness to use
medRxiv · 2023
- Prevalence and determinants of cervicovaginal, oral, and anal HPV infection in a population of transgender and gender diverse people assigned female at birth
medRxiv · 2023
- Data from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Data from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Supplemental Materials from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Supplemental Figure 2 from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Supplemental Figure 1 from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Supplemental Figure 2 from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Supplemental Figure 1 from Prevention of Tumor Growth Driven by <i>PIK3CA</i> and HPV Oncogenes by Targeting mTOR Signaling with Metformin in Oral Squamous Carcinomas Expressing OCT3
2023
- Head & Neck×4
- medRxiv×4
- Clinical Cancer Research×3
- International Journal of Radiation Oncology*Biology*Physics×3
- Molecular Cancer Research×2
- Thomas E. Carey
Medicine · University of Michigan
- Pratyusha Yalamanchi
Medicine · University of Michigan
- Chandan Bhambhani
Medicine · University of Michigan
- Marisa R. Buchakjian
Medicine · University of Michigan
- Lora Campredon
Medicine · University of Michigan
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 25, 2026.
Claim or correct this profile